Positron Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a POSC research report →
Companywww.positron.com
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
- CEO
- Adel Abdullah
- IPO
- 1999
- Employees
- 19
- HQ
- Niagara Falls, NY, US
Price Chart
Valuation
- Market Cap
- $25.70M
- P/E
- -5.66
- P/S
- 49.12
- P/B
- 368.10
- EV/EBITDA
- -2.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -442.23%
- Op Margin
- -1980.45%
- Net Margin
- -1996.28%
- ROE
- -767.26%
- ROIC
- -583.47%
Growth & Income
- Revenue
- $461.45K · -21.45%
- Net Income
- $-10,603,392 · -344.01%
- EPS
- $-0.34 · -269.97%
- Op Income
- $-10,498,463
- FCF YoY
- -177.28%
Performance & Tape
- 52W High
- $2.74
- 52W Low
- $1.25
- 50D MA
- $1.87
- 200D MA
- $1.73
- Beta
- 0.11
- Avg Volume
- 47.87K
Get TickerSpark's AI analysis on POSC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our POSC Coverage
We haven't published any research on POSC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate POSC Report →